Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer

Transl Androl Urol. 2015 Jun;4(3):355-64. doi: 10.3978/j.issn.2223-4683.2015.04.11.


The management of advanced castration resistant prostate cancer (CRPC) has been rapidly changing and is still evolving. In the last years, there has been an increasing knowledge of prostate cancer biology. New therapeutic agents and approaches have been evaluated demonstrating benefits in survival and quality of life in patients with metastatic prostate cancer.

Keywords: Prostate cancer; chemotherapy; hormonal therapy.

Publication types

  • Review